ADAMⅡ is a bench top fluorescent CD34 counter that can be used in hematopoietic stem cell transplant for stem cell therapy.
ADAMⅡ started to release officially after receiving an approval from US FDA 510(k) on 08/09/2019.
ADAMⅡ is an image-based fluorescence cell counter, which captures and analyzes multiple images.
It has 4-channel (Bright, Yellow (PE), Red (PerCP) and Green (FITC)) light sources.
Following specimens can be analyzed: normal and mobilized peripheral blood (PB/MPB), as well as fresh hematopoietic progenitor cell-apheresis (HPC-A) collection.
ADAMⅡ measures the percentage of viable CD34 positive cells from total leukocytes and absolute number of CD34 positive cells (cells/μL).